] i elevation, and GSIS. Fh1 loss resulted in elevated intracellular fumarate, promoting succination of critical cysteines in GAPDH, GMPR, and PARK 7/ DJ-1 and cytoplasmic acidification. Intracellular fumarate levels were increased in islets exposed to high glucose and in islets from human donors with type 2 diabetes (T2D). The impaired GSIS in islets from diabetic Fh1bKO mice was ameliorated after culture under normoglycemic conditions. These studies highlight the role of FH and dysregulated mitochondrial metabolism in T2D.
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INTRODUCTION
Diabetes is an increasing and serious global health and financial problem (Ashcroft and Rorsman, 2012) , characterized by defective insulin secretion from the b cells of the pancreatic islets, which causes elevated blood glucose. Mitochondrial production of ATP plays a key role in glucose-stimulated insulin secretion (GSIS) (Maechler and Wollheim, 1999) ; an increase in intracellular ATP closes ATP-sensitive K + channels (K ATP channels) in the b cell plasma membrane, triggering depolarization and Ca 2+ -dependent electrical activity. The resulting rise in cytoplasmic Ca 2+ initiates exocytosis of insulin granules. In addition to this ''triggering'' effect, glucose amplifies insulin secretion at a stage subsequent to Ca 2+ influx. Several intracellular factors might mediate this amplifying effect, including ATP, NADPH, and glutamate (Henquin, 2011) . The Krebs-cycle enzyme fumarate hydratase (FH) catalyzes the hydration of fumarate to malate. FH is also a tumor suppressor, mutated in hereditary leiomyomatosis and renal cell cancer (HLRCC) (Launonen et al., 2001 ). Loss of FH activity results in the intracellular accumulation of fumarate, the stabilization of hypoxia-inducible factor 1a (HIF1a), and activation of HIF-dependent pathways, including glucose metabolism (Adam et al., 2014) .
The high levels of fumarate that accumulate in FH-deficient cells cause post-translational modification of cysteine residues in proteins to form S-(2-succino)-cysteine (2SC), a process known as succination (Alderson et al., 2006) . This induces loss of activity of the mitochondrial Krebs-cycle enzyme aconitase (Ternette et al., 2013) , activation of the antioxidant response sensor nuclear factor (erythroid-derived 2)-like 2 (NRF2) , and elevation of reactive oxygen species (ROS) signaling (Sullivan et al., 2013; Zheng et al., 2015) . Succination has been described in fat and skeletal muscle cells of some diabetic animal models (Nagai et al., 2007; Thomas et al., 2012) . Its functional consequences include inactivation of the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Merkley et al., 2014; Blatnik et al., 2008) .
HIF1a is a known regulator of GSIS (Girgis et al., 2012; Spé gel et al., 2011) . Deletion of von Hippel-Lindau protein (Vhl), an integral component of the HIF1a degradation pathway, in b cells leads to HIF1a stabilization, a switch from oxidative to glycolytic metabolism and consequent glucose intolerance (Zehetner et al., 2008; Cantley et al., 2009 ). The high levels of fumarate that result from FH loss competitively inhibit the 2-oxoglutarate-dependent dioxygenases that catalyze HIF prolyl hydroxylation. This allows HIF to escape degradation and results in the activation of HIF target genes (Isaacs et al., 2005; O'Flaherty et al., 2010) , raising the possibility that FH loss might impair insulin secretion via HIF1a stabilization.
We explored the role of FH in insulin secretion using a mouse model in which Fh1 was deleted specifically in pancreatic b cells (Fh1bKO mice). These mice had normal glucose tolerance for the first 6-8 weeks of life, and their b cells had essentially normal properties, including GSIS, despite the lack of a key Krebs-cycle enzyme. However, Fh1bKO mice subsequently developed rapidly progressing diabetes, culminating in severe glucose intolerance, reduced islet insulin content, and almost complete loss of GSIS.
RESULTS

Mice Lacking Fh1 in Pancreatic b Cells Exhibit
Hif1a-Independent Glucose Intolerance We generated animals in which Fh1 was deleted specifically in pancreatic b cells (Fh1 fl/fl Rip2-Cre +/À ; Fh1bKO mice) by intercrossing an Fh1 conditional knockout mouse (Pollard et al., 2007) with mice expressing Cre recombinase driven by the rat insulin promoter (Rip2-Cre mice; Herrera, 2000) . Control (CTL) mice were either Fh1 fl/fl Rip2-Cre À/À or Fh1 fl/+ Rip2-Cre +/À littermates. Deletion of Fh1 in b cells was confirmed at the protein level in islets of 9-to 12-week-old mice (Figure 1) . No marked differences were seen in gross histology between CTL and Fh1bKO mice in islets (Figures 1A and 1F) . Immunohistochemistry (IHC) showed that all cells in CTL islets exhibited uniform expression of FH, which was lost within the core of Fh1bKO islets. However, some islet cells, most likely a and b cells, retained FH ( Figures  1B, 1G , and 1J). Fh1 loss and elevated fumarate lead to stabilization of HIF1a and subsequent nuclear localization (Isaacs et al., 2005; Pollard et al., 2005) . Figures 1C and 1H show nuclear localization of HIF1a in most cells of Fh1bKO islets, but not in CTL islets or the exocrine pancreas. No marked differences were observed in insulin or glucagon IHC between CTL and Fh1bKO islets ( Figures 1D, 1E , 1I, and 1J).
Deletion of Fh1 was confirmed in Fh1bKO islets from 9-to 12-week-old mice at the mRNA level. A small amount of Fh1 mRNA remained in Fh1bKO islets, likely reflecting its presence in non-b cells ( Figure 1K ). Expression of the Hif1a target genes pyruvate dehydrogenase kinase 1 (Pdk1) and prolyl hydroxylase dehydrogenase 3 (Phd3/Egln3) was increased in Fh1bKO islets ( Figure 1K ).
Blood glucose levels were measured in free-fed CTL and Fh1bKO littermates from 6 to 20 weeks. While young (6-8 weeks of age) Fh1bKO mice were nearly normoglycemic, they subsequently (at >9 weeks of age) developed severe hyperglycemia (>20 mM) ( Figure 1L ). Plasma glucose in CTL mice was stable at all ages (<10 mM). For simplicity, here we refer to CTL and Fh1bKO littermates at 6-8, 9-12, and >15 weeks of age as stages I-III, respectively, to match the progressive diabetes in Fh1bKO mice. Stages I (non-diabetic [ND]), II (diabetic), and III (severely diabetic) have free-fed blood glucose levels of 12.8 mM ± 0.6 mM, 22.6 mM ± 1.2 mM, and 30.4 mM ± 0.9 mM ( Figure 1L ). The progression of diabetes was confirmed in glucose tolerance tests, which revealed mild intolerance between 9 and 12 weeks of age (stage II) and severe intolerance by 15 weeks (stage III) ( Figures 1M and 1N ). No age-dependent deterioration of glucose tolerance was observed in CTL mice.
To assess whether the glucose intolerance of Fh1bKO mice is mediated by HIF1a stabilization, we crossed Fh1bKO and Hif1a fl/fl mice (Cramer et al., 2003) to produce b cell-specific deletion of both Fh1 and Hif1a (Fh1Hif1abKO mice). Deletion of Hif1a, confirmed by loss of HIF1a staining in all nuclei of Fh1Hif1abKO islets ( Figure 1O ), did not ameliorate the glucose intolerance of Fh1bKO mice ( Figure 1P ). Loss of Fh1 also leads to stabilization of NRF2 and activation of downstream pathways, typified by increased expression of Hmox1 (confirmed in Figure S1D ) . The role of Nrf2 in b cell function is unclear, proposed to protect from oxidative damage and blunt GSIS (Uruno et al., 2013) . To determine the contribution of Nrf2 to glucose homeostasis, we crossed Fh1bKO with a constitutive knockout of Nrf2 (Itoh et al., 1997) to delete both Fh1 and Nrf2 in the b cell (Fh1bNrf2DKO). The glucose intolerance of Fh1bKO mice was unaltered in the Fh1bNrf2DKO mice ( Figure S1A ). In contrast, crossing Fh1bKO mice with mice stably expressing either full-length human FH (Fh1bKO+FH) or cytoplasmic FH (FH cyt ) (Fh1bKO+FH cyt ) (Adam et al., 2013) fully reversed the glucose intolerance tested in stage III mice and restored the mRNA expression of Egln3 and Hmox1 (Figures 1Q and S1B-S1D), and these mice were normoglycemic for >1 year.
Deletion of Fh1 in b Cells Results in Progressive Loss of GSIS
To explore the cause of glucose intolerance in Fh1bKO mice, we examined insulin secretion from the perfused pancreas. Glucose elevation from 1 mM to 6 mM transiently stimulated insulin release $10-fold in stage II CTL mice but not in Fh1bKO littermates ( Figure 2A) . Nevertheless, the response to 20 mM glucose was almost superimposable in both genotypes. In stage III Fh1bKO mice, the response to both 6 mM and 20 mM glucose was 85% less than in CTL ( Figure 2B ). Similar effects on GSIS were obtained in static incubations ( Figure S2 ). The mitochondrial substrate a-ketoisocaproic acid (a-KIC) stimulated insulin secretion $5-fold in CTL islets but had no effect in Fh1bKO islets ( Figure S2 ).
These differences in insulin release correlated with a reduction in insulin content. In islets from stage II mice, insulin content and insulin granule density were reduced by $50% in Fh1bKO islets ( Figures 2C-2E ). Pancreatic insulin content was 97% less in stage III Fh1bKO mice, compared to CTL littermates ( Figure 2F) , and there was a marked decrease in insulin-positive cells (Figure 2G) . When insulin secretion data are normalized to basal values, secretion from stage II Fh1bKO islets remains strongly reduced, suggesting that there is a functional defect ( Figure S2 ).
Fh1bKO Islets Exhibit Dysregulated Metabolism
As mitochondrial metabolism plays a key role in GSIS (Ashcroft and Rorsman, 2012) and Fh1 deletion disrupts the Krebs cycle, we analyzed glucose utilization ( 3 H 2 O production, reflecting combined flux through the glycolytic and pentose phosphate pathways) and oxidation (CO 2 production, reflecting mitochondrial metabolism) (Hellman et al., 1971) . In both CTL and Fh1bKO stage II islets, glucose oxidation increased 4-fold when glucose was increased from 1 to 20 mM ( Figure 3A ). Glucose utilization also increased 4-fold, but the effect was 35%-40% greater in Fh1bKO than CTL islets ( Figure 3B ), suggestive of increased aerobic glycolysis (O'Flaherty et al., 2010) . Metabolite analysis in islets from stage II mice confirmed an overall pattern of changes similar to that observed in other FHdeficient cells Frezza et al., 2011) . In particular, levels of fumarate, argininosuccinate, and adenylosuccinate were increased, and aspartate was reduced ( Figure 3C ; Table S1 ), indicating that FH loss leads to stimulation of the urea cycle/arginine biosynthesis pathway (Adam et al., 2013; Zheng et al., 2013) . Levels of AMP, uridine monophosphate (UMP), and guanosine monophosphate (GMP) were decreased, suggesting both purine and pyrimidine metabolism are compromised as a consequence of aspartate depletion, but likely reflect altered adenylosuccinate metabolism due to elevated fumarate (Bulusu et al., 2011) . Importantly, no difference was observed in oxidized or reduced glutathione between CTL and Fh1bKO islets, suggesting no major change in ROS or ROS signaling (Sullivan et al., 2013) . Islet fumarate and argininosuccinate content were normalized following re-expression of either FH or FH cyt in mice ( Figures S3A and S3B ). The lack of FH means there is a loss of Krebs-cycle intermediates for every glucose molecule entering the mitochondria. Since metabolism might be maintained by enhanced utilization of amino acids (anaplerosis), we measured 16 key amino acids in islets at both 1 mM and 20 mM glucose. Glucose elevation increased levels of 15 amino acids in CTL islets but had little effect in stage II Fh1bKO islets ( Figures 3D, S3C , and S3D).
Glutamate may play a key role in both glucose-and incretininduced insulin secretion, via the amplifying (non-K ATP -dependent) pathway (Maechler and Wollheim, 1999) . Because the glucose-induced increase in glutamate was lower in Fh1bKO islets than in CTL islets ( Figure 3D ), we investigated the amplifying pathway of insulin secretion using islets from stage II animals depolarized with 70 mM extracellular K + (to test the amplifying effect of glucose). Increasing glucose from 2 mM to 20 mM amplified insulin secretion by 600% in CTL islets but only by 150% in Fh1bKO islets ( Figure 3E ). Addition of exogenous membrane-permeable dimethyl glutamate (DMG; 5 mM) had no effect in CTL islets at either 2 mM or 20 mM glucose but potentiated GSIS in Fh1bKO islets in response to 20 mM glucose ( Figure 3E ). This suggests that the lack of intermediates, including glutamate, may underlie the impaired insulin release of Fh1bKO islets. Exogenous membrane-permeable dimethyl fumarate (DMF; 5 mM) did not inhibit insulin secretion in CTL islets ( Figure 3F ), indicating that the acute increase of intracellular fumarate in Fh1bKO islets is not the cause of the impaired GSIS.
Some aspects of altered metabolism in Fh1bKO islets were also investigated by comparing glutamine (m0 to m+5) and glucose (m0 to m+6) isotopomers in islets from stage II Fh1bKO and CTL mice incubated in 1 mM or 20 mM glucose with either [U-
13
C 5 ]-glutamine or 13 C 6 -glucose ( Figure S4 ). Increased levels of fumarate and argininosuccinate, derived from glutamine, were observed in islets subsequently exposed to 20 mM glucose (Figures S4C and S4D) . Islets cultured at 20 mM glucose utilized glutamine to generate uridine 5'-diphosphate (UDP)-N-acetylglucosamine ( Figures S4H and S4M ), a precursor for synthesis of glycosaminoglycans, proteoglycans, and glycolipids (Bond and Hanover, 2013) . Substitution of the isotopomers m+2, m+3, m+4, and m+5 for the naturally occurring m+0 and m+1 forms was increased significantly in both glutamate and aspartate in both CTL and Fh1bKO in islets incubated with 20 mM glucose ( Figures S4J, S4L, S4N , and S4O). (C) Heatmap of metabolites (measured by CE-TOFMS) that show significant concentration differences between islets from stage II CTL (n = 8 mice) and Fh1bKO (n = 7 mice) mice incubated at 5 mM glucose for 1 hr. Red and green for Fh1bKO islets indicate metabolites that are significantly increased or decreased, respectively, versus CTL islets (p < 0.05); Student's t test. Each column represents values for islets from one animal. Absolute values are given in Table S1 . Branch points indicate metabolites linked in common pathways. (D) Amino acid content in islets of stage II Fh1bKO (gray; n = 12) and CTL (black; n = 8) mice at 20 mM glucose, expressed relative to that at 1 mM glucose (20G/1G) (n = 30 islets per group analyzed in triplicate in 5 experiments). Abbreviations: Asp, aspartate; Glu, glutamic acid; Ser, serine;Gln, glutamine; His, histidine; Gly, Progressive Loss of GSIS in Fh1bKO Mice Correlates with Reduced ATP Production and b Cell Electrical Activity Next, we compared the effects of glucose on ATP production and electrical activity in CTL and Fh1bKO mice. The glucoseinduced increase in the ATP/ADP ratio was identical in stage I Fh1bKO and CTL islets ( Figure 4A ). However, b cells in islets from stage III Fh1bKO mice exhibited far smaller glucoseinduced increases in the ATP/ADP ratio than age-matched CTL b cells ( Figures 4B and 4C ). Glucose-induced electrical activity in b cells from stage II Fh1bKO mice was similar to that of CTL islets ( Figure 4D ). However, clear differences were observed in stage III mice. Whereas CTL b cells responded to 20 mM glucose with membrane depolarization and action potential firing, b cells in stage III Fh1bKO islets were refractory to glucose stimulation ( Figure 4E ). In such glucose-unresponsive Fh1bKO b cells, electrical activity was elicited by the K ATP -channel blocker tolbutamide. Together, these data suggest that glucose is unable to inhibit K ATP channels in stage III Fh1-deficient b cells, because ATP generation is reduced. 
Protein Succination in Diabetic Islets
Fumarate reacts with cysteine residues in proteins in a non-enzymatic process known as succination. Using an antibody (2SC) that labels succinated proteins specifically (Blatnik et al., 2008) , we confirmed that succination was detected in Fh1bKO b cells and not in CTL b cells ( Figures 5A and 5B) .
Culture of adipocytes in high glucose elevates fumarate and results in protein succination (Nagai et al., 2007) . Therefore, we determined quantitatively whether hyperglycemia would increase fumarate in islets. Fumarate levels were $100-fold higher in stage II Fh1bKO islets, even after 1 hr incubation at 1 mM glucose, yet they were further increased at 20 mM glucose (Figure 5C ). Glucose also increased fumarate levels in CTL islets; 1 hr incubation at 20 mM glucose increased fumarate levels 12-fold, compared to islets incubated at 1 mM glucose. This was not due to a reduction in FH ( Figure 5D ) and, thus, is likely a consequence of the enhanced glucose metabolism. Similar acute (1 hr) effects of high glucose on fumarate content were observed in ND human islets ( Figures 5E and 5F ). Interestingly, the fumarate content of islets from donors with type 2 diabetes (T2D) was higher than that in ND islets, and high glucose produced no further increase ( Figure 5F ).
Tandem mass spectrometry (MS/MS) analysis of islets from stage II Fh1bKO mice islets detected succination of key cysteine residues in glyceraldehyde 3-phosphate dehydrogenase (GAPDH; residue C150) ( Figures 5G and 5H) , guanosine monophosphate reductase (GMPR; C186) ( Figure S6A ; Table  S2 ), and Parkinson's disease (autosomal recessive, early onset) 7 (PARK 7/DJ-1; C106). Succination of PARK7/DJ-1 (C106) was also observed in islets from a human T2D donor ( Figure S6B ; Table S2 ).
Succination of residue C150 of GAPDH was increased by 270% in Fh1bKO islets ( Figures 5G and 5H) . Succination of GAPDH, detected in the gastrocnemius muscle of diabetic rats, has been shown to reduce enzyme activity (Blatnik et al., 2008) . This might limit glucose flux through glycolysis, leading to accumulation of upstream glycolytic 3-and 6-carbon intermediates. We tested the possible functional consequences by culturing CTL islets for 24 hr in the presence of 10 mM of the triose D-glyceraldehyde. This resulted in the complete loss of GSIS and correlated with a slight increase in islet insulin content ( Figures S7A and S7B) .
Impact of Fh1 Deletion on Cytosolic Calcium and pH
Links have been proposed between glucose and pH i (Shepherd and Henquin, 1995 Figure 4E) . Although basal pH i was slightly lower in b cells from stage I Fh1bKO mice than in CTL cells (as expected from the elevated fumarate), the responses to glucose and glyceraldehyde were similar ( Figures  6A, 6B , and 6E): glucose and glyceraldehyde lowered pH i glycine; Thr, threonine; Arg, arginine; Tau, taurine; Ala, alanine; Tyr, tyrosine; GABA, gamma aminobutyric acid; Val, valine; Phe, phenylalanine; Ile, isoleucine; Leu, leucine. (E) Insulin secretion from islets from stage II Fh1bKO (gray) and CTL (black) islets (n = 4 experiments; n = 3 mice per genotype) in the presence of 70 mM KCl and 2 mM or 20 mM glucose and 5 mM dimethylglutamate (DMG), as indicated. **p < 0.01 versus 2 mM glucose in Fh1bKO; ***p < 0.0001 versus 2 mM glucose (CTL); xx p < 0.01 CTL versus Fh1bKO in 20 mM glucose.
(F) Insulin secretion in wild-type islets (n = 13 experiments; n = 3 mice) at 1 mM and 20 mM glucose with the addition of dimethyl fumarate (5 mM DMF). **p < 0.001 or better versus 1 mM glucose. Error bars represent ± SEM. See also Figures S3 and S4 and Table S1 . (Figures 6D and 6E ).
Impaired GSIS in Fh1bKO Islets Is a Consequence of Hyperglycemia
We reasoned that the deterioration of GSIS in Fh1bKO islets over time might be a consequence of the progressive hyperglycemia (Brereton et al., 2014) . We tested whether the impairment of GSIS could be reversed. Freshly isolated islets from stage III Fh1bKO mice were refractory to 6 mM glucose, and the response to 20 mM glucose was only 30% of that seen in CTL islets ( Figure 7A ), echoing the data from the perfusion experiments ( Figure 2B) .
After culture at 12 mM glucose for $65 hr, secretory responses in CTL islets were essentially the same as in freshly isolated islets. However, GSIS at 20 mM glucose was dramatically improved in Fh1bKO islets and approached that of the CTL islets ( Figure 7B ). Insulin content was 35% lower in Fh1bKO than in CTL islets ( Figure 7C ).
Finally, we tested whether the loss of GSIS in stage III Fh1bKO islets reflects a direct ''glucotoxic'' effect or is related to accelerated glucose metabolism. Distinct from what was seen following culture at 12 mM glucose ( Figures 7A and 7B) , islets from stage III Fh1bKO mice cultured for 3 days at 20 mM glucose showed no recovery of GSIS. By contrast, islets cultured in the presence of the glucokinase inhibitor mannoheptulose (Zelent et al., 2005; Coore and Randle, 1964) exhibited some (limited) glucose responsiveness ( Figure 7D ).
DISCUSSION
We show here that lack of the Krebs-cycle enzyme FH causes a progressive deterioration of b cell function, resulting in severe diabetes associated with impaired oxidative metabolism, ATP production, intracellular calcium handling, and cytosolic acidification.
Distinct from the mouse model in which Vhl is deleted in b cells (Zehetner et al., 2008; Cantley et al., 2009) , we found that the diabetes associated with Fh1 loss is Hif1a and Nrf2 independent. Our data are consistent with earlier observations that, while Fh1 deletion leads to the accumulation of fumarate, and HIF1a is stabilized, many associated functional changes are independent of HIF1a (O'Flaherty et al., 2010; Adam et al., 2013; Ternette et al., 2013) . Similar to previous studies, we were unable to detect HIF1a in normal b cells, and deletion of Hif1a alone did not disrupt glucose homeostasis (Zehetner et al., 2008; Cantley et al., 2009 ). However, it remains unclear whether b cell dysfunction and diabetes are caused by HIF1a stabilization or vice versa (Cantley et al., 2010; Girgis et al., 2012) . In the Fh1bKO mouse, loss of glucose regulation appears entirely attributable to FH. The hyperglycemia that develops may drive HIF1a stabilization, perhaps compounding GSIS impairment further in a feedback loop.
Why Do Young (Stage 1) Fh1bKO Mice Have Normal Glucose Tolerance?
Given the importance of mitochondrial metabolism for insulin secretion, the mild phenotype of stage I Fh1bKO mice was (legend on next page) surprising, not least as Fh1 deletion led to >100-fold accumulation of fumarate, consistent with arrest of the Krebs cycle at FH. Because insulin secretion was unimpaired, this suggests that refilling of Krebs-cycle intermediates (anaplerosis) must occur distal to FH. Labeling experiments in mouse embryonic fibroblasts (MEFs) lacking Fh1 show that fumarate exits the mitochondria to the cytoplasm but is then metabolized to aspartate via the urea cycle, which re-enters the Krebs cycle (Adam et al., 2013) . Studying metabolism in murine pancreatic islets is difficult because of the limited amounts of material available, especially from the diabetic islets. Our analyses of Fh1bKO islets by capillary electrophoresis time of flight MS (CE-TOFMS) indicate similar disruption of the urea cycle and purine metabolism and explain, in part, why the diabetic phenotype of Fh1bKO mice can be rescued by re-expression of cytosolic FH. Moreover, Fh1bKO islets exhibit increased utilization and oxidation of glucose, consistent with aerobic glycolysis, recapitulating previous observations made when Fh1 was deleted in MEFs and mouse kidney (O'Flaherty et al., 2010; Adam et al., 2013) . Normally, excess Krebs-cycle reactants are used to produce amino acids via cataplerosis (Choi et al., 2011; MacDonald et al., 2005) . However, in Fh1bKO islets, amino acid content tended to be reduced, and glucose did not increase the content of several amino acids; for example, glutamate. This is of interest because glutamate has been implicated in the amplification of GSIS (Maechler and Wollheim, 2000) . Exogenous dimethyl glutamate restored GSIS in Fh1bKO islets but had no effect in CTL islets. These data support the idea that glutamate functions as an ''amplification signal.'' Another possibility is that exogenous glutamate may restore GSIS by feeding into the Krebs cycle and partially restoring mitochondrial metabolism (Frezza et al., 2011) .
Despite the $50% reduction in insulin content, the response to 20 mM glucose was maintained in stage II Fh1bKO mice. We speculate that Fh1bKO b cells may compensate for the reduction of insulin content by stimulation of insulin exocytosis. Fh1bKO islets contain significantly elevated levels of adenylosuccinate, which has been proposed to stimulate exocytosis by inhibition of the sentrin/SUMO-specific protease 1 (Gooding et al., 2015) .
Rapid Progression to Diabetes in Stage II Fh1bKO Mice
Once slight hyperglycemia developed, rapid deterioration of glycemic control was observed (up to 10 mM/week). We speculate that a small elevation of plasma glucose induces a vicious cycle of impaired insulin secretion and hyperglycemia. In part, this arises because, as blood glucose increases, more glucose enters metabolism, causing even greater stress on the b cell with increased fumarate levels. It is possible that metabolism of cytosolic fumarate and anaplerosis eventually become unable to maintain the Krebs cycle and that, once this occurs, rapid deterioration of both GSIS and glucose tolerance occurs.
Why Do Fh1bKO Mice Become Glucose Intolerant?
Our results indicate that Fh1bKO mice eventually develop diabetes because glucose is no longer able to stimulate insulin secretion. This is because of a failure of mitochondrial metabolism that culminates in impaired ATP production, defective K ATP -channel closure, and suppression of electrical activity and [Ca 2+ ] i .
Why does ATP production fail? Pumping H + across the inner mitochondrial membrane, the electron transport chain produces the alkalinization of the mitochondrial matrix (Wiederkehr et al., 2009) and membrane hyperpolarization, which are needed to drive ATP synthesis in b cells. Fumaric acid (C 4 H 4 O 4 ) is an acid with two hydroxyl groups with pKa of 3.0 and 4.4; thus, loss of FH activity can accordingly be expected to result in acidification not just of the cytoplasm (experimentally measured) but also of the mitochondrial matrix.
There is a sigmoidal relationship between glucose concentration and mitochondrial metabolism (Ashcroft et al., 1970; Hellman et al., 1971) . At low glucose concentrations, the Krebs cycle runs at a fairly low rate, and the amount of fumarate generated and deposited in the cytosol will be low. Thus, if Fh1bKO mice remain normoglycemic, cytoplasmic acidification will be modest. In agreement with this idea, glucose-responsive b-cells (B) Immunofluorescence for 2SC (green), insulin (red), glucagon (purple), nuclei (blue), and overlay in a representative islet from a stage III Fh1bKO mouse (n > 100 islets from n > 10 Fh1bKO mice). Scale bar, 20 mm. (C) Fumarate content determined by CE-TOFMS in islets from stage II Fh1bKO mice (gray; all islets from n = 6 mice) and CTL mice (black; all islets from n = 6 mice) incubated for 1 hr at 1 mM or 20 mM glucose. **p < 0.01 versus 1 mM glucose; xxx p < 0.01 versus CTL.
(D) Western blot of FH protein in islets from stage II CTL mice (all islets from n = 3 mice) cultured for 24 hr at 5 mM or 20 mM glucose. Cnx, calnexin, loading control. (E) Fumarate content measured by CE-TOFMS of islets from human ND donors (4 donors) incubated for 1 hr at 1 mM or 20 mM glucose. **p < 0.01 versus 1 mM glucose.
(F) Fumarate content determined by gas chromatography-mass spectrometry (GC-MS) in human ND (31 donors) or T2D (7 donors) islets cultured at 2.8 mM and 16.7 mM glucose. Content is expressed relative to that of ND islets at 2.8 mM glucose. : doubly charged fragment ion. Both theoretical mass (in brackets) and detected mass are given for each assigned fragment ion. Peptide fragments that include the succinated cysteine residue are highlighted in red, while unsuccinated fragments are depicted in green. Insets in (G) and (H) show the extracted ion chromatograms of the precursor peptide from a representative triplicate run of analyzed pancreatic islets. Quantification of the peptide, corresponding to residues 144-160 of Gapdh, succinated at C150, indicate that the succinated peptide was enriched by 270%, while the unmodified peptide was decreased by 70%. PE indicates the modification of cysteine residues at C150 and C154 to pyridylethyl-cysteine in the inset in (G) and only C154 in (H). Error bars represent ± SEM. See also Figure S6 and Table S2. from stage I Fh1bKO mice had a higher pH i than b cells from stage III mice. At higher plasma glucose levels, mitochondrial glucose metabolism will accelerate due to the increased substrate, leading to greater fumarate generation, acidification of both cytoplasmic and mitochondrial matrices, and a progressive impairment of ATP production. Also, acidification may influence the activity of other enzymes involved in b cell metabolism with optimal activity at alkaline pH (e.g., Bernstein and Everse, 1978; Lai and Cooper, 1986; Willson and Tipton, 1980) . These effects may be aggravated by downregulation of key genes involved in mitochondrial metabolism, as seen in a mouse model of diabetes caused by a gain-of-function mutation in the K ATP channel (bV59M mice; Brereton et al., 2016) . These scenarios are not mutually exclusive, and it is possible that they operate in parallel and that both contribute to the loss of ATP production and GSIS. Both these hypotheses predict that inhibition of glucose metabolism should exert a protective effect on b cell metabolism. This proved to be the case, as GSIS was restored in Fh1bKO islets following ''normoglycemic'' culture or culture in high glucose with the glucokinase inhibitor mannoheptulose.
Fumarate Accumulation Leads to Protein Succination
Our data demonstrate that elevation of intracellular fumarate is associated with ''hyperglycemia'' in both mouse and human islets. We detected succination of critical cysteines in GAPDH, GMPR, and PARK7/ DJ-1 proteins in Fh1bKO islets. Succination of GAPDH has been reported previously in adipocytes in diabetic db/db and ob/ob mice. It is a marker of impaired mitochondrial metabolism and has functional effects (Blatnik et al., 2008; Frizzell et al., 2011) . Reduced PARK7/DJ1 activity is compatible with the small mitochondria (suggestive of mitochondrial fragmentation and impaired function) seen in Fh1bKO islets. Interestingly, we found that fumarate levels are elevated in islets from T2D donors and may, via succination, explain why expression of PARK7 is reduced in T2D islets (Jain et al., 2012) . Importantly, it also suggests that mitochondrial metabolism is impaired in islets, leading to elevated fumarate and succination.
Conclusions
Our studies suggest a cycle in which progressive hyperglycemia in Fh1bKO mice leads to the deterioration of metabolism, culminating in the loss of GSIS and frank diabetes. Although b cells from young Fh1bKO mice are glucose responsive, subtle differences exist between Fh1bKO and CTL islets. Thus, GSIS is impaired at 6 mM glucose in Fh1bKO mice, compared to CTL mice. This defect may underlie the slight elevation in plasma glucose that precedes the more rapid deterioration in glucose tolerance. Our hypothesis is consistent with the proposal that hyperglycemia, via b cell decompensation, initiates a cycle of progressive hyperglycemia and impaired GSIS (Weir and Bonner-Weir, 2004) .
In severely diabetic mice expressing the gain-of-function K ATP channel mutation V59M (Brereton et al., 2014) , the adverse effects on b cell function and insulin content were reversed following restoration of normoglycemia. Similarly, the severe impairment of GSIS seen in diabetic (stage III) Fh1bKO islets was almost fully corrected simply by culturing the islets under ''normoglycemic'' conditions. This agrees with the report that GSIS is restored in long-term T2D patients following normalization of plasma glucose levels and suppression of hepatic glucose production induced by a low-calorie diet (Lim et al., 2011) .
We propose that the Fh1bKO mouse provides a valuable new model for T2D. In particular, it is not obese, and the glucose intolerance develops in an age-dependent fashion. Thus, it provides a useful tool for studying the progression observed in T2D and to interrogate the systemic and cellular consequences of metabolic dysfunction in the pancreatic b cell without the complications of altered diet and/or obesity.
EXPERIMENTAL PROCEDURES
See also Supplemental Experimental Procedures.
Mice
Animal experiments were conducted in accordance with the UK Animals Scientific Procedures Act (1986) , and Fh1b/Nrf2KO, respectively) and littermate controls (designated CTL). The constitutive Nrf2 KO mouse was generated from an embryonic stem cell (ESC) clone obtained from Riken, Japan. Genotyping was performed by Transnetyx, but primer details and PCR conditions can be obtained from J.A. NMRI and C57BL/6J mice (designated wild-type) purchased commercially were used in a few cases.
IHC
Mouse tissues were fixed in 10% neutral-buffered formalin, dehydrated, and processed for paraffin wax embedding and sectioning (3 mm). H&E sections were generated for all samples. IHC was carried out using the EnVision Kit 
Intraperitoneal Glucose Tolerance Test
Blood glucose levels were determined with an Accuchek Aviva meter after 16 hr of fasting and at time points following intraperitoneal injection of 2 g glucose per kilogram of body weight. Animals were culled at the end of the test, and pancreata were processed as described earlier.
Hormone Secretion and Content Measurements
Insulin secretion was measured by in situ pancreas perfusion or in static incubations of isolated islets (Zhang et al., 2013) . Insulin content was determined in parallel from isolated islets or from mouse pancreata harvested separately. ] i and pH i in mouse islets was performed on the inverted Zeiss AxioVert 200 microscope, equipped with the Zeiss LSM 510-META laser confocal scanning system, using a 403/1.3 NA objective. Mouse islets were loaded with 6 mM of the Ca 2+ -sensitive dye Fluo-4 for 90 min before being transferred to a separate solution containing 6 mM of the pH-sensitive dye SNARF-5F (both dyes from Molecular Probes) for a further 50 min at room temperature and imaged using an open chamber at 34 C. The bath solution containing various stimuli was perifused continuously at the rate of 200 mL/min. The ratiometric dye SNARF-5F was excited at 543 nm, and emission was collected at 650 nm and 600 nm. Fluo-4 was excited at 488 nm and imaged at 530 nm. Images were acquired at the frequency of 0.03 Hz. The pH calibration of each trace was performed using the high K + -nigericin technique. Valinomycin (5 mM) was added to the extracellular solution to abolish the K + gradient (Tarasov et al., 2012 .
Statistical Analysis
Image sequences were analyzed (registration, background subtraction, ROI intensity versus time analysis) using open-source FIJI software (http://fiji.sc/ Fiji). The numerical time series data were analyzed using the IgorPro package (Wavemetrics). Statistical significance of the differences between paired or unpaired samples was tested using Friedman or Kruskall-Wallis tests, respectively, with Nemenyi post hoc analysis, as implemented in the R package (R Development Core Team, 2016) . Basal pH i was calculated by taking the mean of the first 15 SNARF-5F ratio values from each cell. After glyceraldehyde and 20 mM glucose application, pH i was calculated by taking a mean of the values when the SNARF-5F ratio reached a nadir. Differences with p < 0.05 were considered significant. Cells that were not active at 3 mM glucose and that responded to high glucose with the characteristic [Ca 2+ ] i oscillations were taken as b cells.
All data are given as mean ± SEM unless indicated that they are mean ± SD. Other than for image analysis, as indicated earlier, statistical significance was determined with significance set at <0.05, using either ANOVA with Tukey's multiple comparison or Student's t test (where indicated). Statistical significance was determined using GraphPad Prism v.6.0d (GraphPad Software, La Jolla, CA, USA; http://www.graphpad.com).
Human Islets and Ethics
Pancreatic islets were isolated from deceased donors under ethical approval obtained from the local human research ethics committees in both Oxford and Lund. All donors gave informed research consent. Islets were obtained from the Diabetes Research & Wellness Foundation Human Islet Isolation Facility, OCDEM, University of Oxford, and the Nordic Center for Clinical Islet Transplantation (http://www.nordicislets.com; Uppsala, Sweden) via the Human Tissue Laboratory at Lund University Diabetes Centre. Islets were hand picked, and their quality was assessed prior to research use. Experiments in Oxford were performed using islets from donors (5 females and 1 male) with the following parameters: age, 47.8 years ± 6.7 years; BMI, 28.4 ± 5.8. In Lund, the characteristics of ND (n = 31, CTL) and diabetic (n = 7, T2D) islet donors were as follows: age (years), 61.24 ± 10.45 (CTL) and 60.43 ± 7.72 (T2D), p = 0.82; sex, expressed as male/female, 14/7 (CTL) and 2/5 (T2D), p = 0.44; BMI, 27.11 ± 3.06 (CTL) and 28.9 ± 5.35 (T2D), p = 0.42; and HbA1c, 5.85 ± 0.45 (CTL) and 6.41 ± 0.56, p = 0.04. Data are given as mean ± SD; groups were compared using the Student's t test or using two-tailed Fisher's exact test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, seven figures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2017.08.093.
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